Anticoagulants and fibrinolytics Flashcards
What are the common therapeutic applications of anti-coagulants?
Alonside aspirin and antiplatelets = used to treat unstable angina and prevent STEMi.
Used prophylactically to reduce risk of stroke, TIA and Deep vein thrombosis + Pulmonary embolism…. (Risk with Atrial fibrillation)
Thromboprophylaxis = before, during and after surgeries as well as broken/fractured bones….
= AFter a hip/knee replacement or during a heart surgery..
What are common adverse reactions to anti-coagulants?
Subcutaneous haemorrhages.
Bleeding.
Immune thrombocytopenia = reduced platelets with heparins/LMWHs (complexed with Platelet factor 4)…
(Less common with Fondaparinux)!!!
Adverse reactions to warfarin?
Teratogenicity = DONT GIVE TO PREGNANT WOMEN!!!
As well as subcutaneous haemorrhage and bleeding.
Adverse reactions to heparin?
+ Fondaparinux?
Heparin and LMWHs can cause:
Bleeding + Subcutaneous haemorrhage.
Immune thrombocytopenia = reduced platelets = NOT with Fondaparinux
With long term use lead to Osteoporosis…
Adverse reactions to Protamine sulfate?
HYPERSENSITIVITY + ANAPHYLAXIS.
Antidote to UFH unfractionated heparin./.
What is the MoA of fibrinolytics?
What are the fibrinolytics?
Ateplase, Streptokinase and Urokinase = recombinant tPA.
= Clot busters.
Plasminogen is precursor of plasmin.
tPA and uPA are endogenous plasminogen activators.. convert plasminogen to plasmin.
Plasmin converts insoluble fibrin into soluble fibrin and dissolves the clot.
Endothelial cell injury inhibits plasminogen activation by releasing PAI-1, which inhibits uPA/tPA….
What are the therapeutic uses of fibrinolytics?
In acute myocardial infarction = dissolve thrombus and reduce further ischaemic damage.
Acute thrombotic stroke!!! = recombinant tPA
Thrombembolisms = Streptokinase
What is the antidote to fibrinolytics?
Tranexamic acid = Competitive inhibitor of plasminogen activation by blocking the binding sites for tPA and uPa,
which are endogenous plasminogen activators.
= Promoting clot formation…
High doses block plasmin itself - but dose-dependence side effects….
What are the therapeutic uses of Tranexamic acid?
Haemorrhage complications in thrombolytic surgery.
Heavy menstrual bleeding.
Prophylaxis in patients with high risk of haemorrhages… haemophiliacs, biopsies…
ADverse effects of Tranexamic acid?
Nausea, vomiting + diarrhoea which is dose dependent….
High doses of Tranexamic acid also inhibit plasmin itself..
What are the main steps in extrinsic coagulation cascade?
Endothelial layer damage e.g. atheromatous plaque rupture, exposure of subendothelial layer..
= triggers TF release from leukocytes.
TF binds Factor VII = forming active TF:Factor VIIa complex.
TF:Factor VIIa complex cleaves and activates Factor X.
Factor Xa cleaves prothrombin (Factor II) and forms Thrombin (Factor IIa)…
Thrombin (IIa) converts fibrinogen to Fibrin - Fibrinogen bound on GPIIb/IIIa of activated platetets.
Thrombin converts Factor XIII into Factor IIIa = which cross-links soluble fibrin into a stabilising matrix…
Where do the Extrinsic and Intrinsic pathways converge?
TF:VIIa complex of extrinsic cascade activates Factor X.
Intrinsic pathway IXa activates Factor X.
What are the bodies endogenous anti-coagulants?
ATIII = Anti-thrombin III.
Heparins!
= which inhibit thrombin, Xa, IXa formations…
What is UFH?
UFH is a mixture of naturally occurring heparins - mucopolysaccharides = highly negatively charged.
Heparins between 5k-40kDa…
Extracted from blood with the heparins released from Mast cells and basophils!!!
Where are endogenous heparins released from?
Endogenous heparins (inhibit Xa and thrombin formation)….
Released by Mast Cells and Basohpils…